Status:
COMPLETED
The Glycaemic and Insulinaemic Responses of Camel Milk
Lead Sponsor:
Wageningen University
Conditions:
Healthy
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
Rationale: Recently, human, animal and epidemiological studies suggested that camel milk has a hypoglycaemic activity. However, a mechanism and reasons for this activity have not been sufficiently stu...
Detailed Description
There is no detailed description
Eligibility Criteria
Inclusion
- Healthy: as judged by the subjects;
- Age: 18 to 35.
Exclusion
- Pregnant or lactating females;
- Presence of a chronic disease such as diabetes, illness, dysmetabolic syndrome;
- 5 \> BMI \> 25 kg/m2;
- Lactose intolerance or experiencing discomfort after milk consumption;
- Weight loss or gain of more than 5 kg in the last two months;
- Using an energy restricted diet during the last 2 months;
- Fasting blood glucose levels \>100 mg/dl or 5.6 mmol/l (18);
- Smokers;
- Use of medications other than birth control, paracetamol, aspirin, asthma or hay fever;
- Previous problems with blood sampling.
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01498523
Start Date
December 1 2011
End Date
February 1 2012
Last Update
February 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wageningen University
Wageningen, Gelderland, Netherlands, 6703 HA